dc.contributor.author |
Tekle, Esayas |
|
dc.contributor.author |
etal |
|
dc.date.accessioned |
2023-04-05T06:58:20Z |
|
dc.date.available |
2023-04-05T06:58:20Z |
|
dc.date.issued |
2023-04-05 |
|
dc.identifier.uri |
http://hdl.handle.net/123456789/5758 |
|
dc.description.abstract |
Baseline PT at a cut-off value � 16.25 seconds differentiated severe COVID-19 patients
from mild and moderate patients (AUC: 0.89, 95% CI: 0.83–0.95). PT also differentiated
mild COVID-19 patients from moderate and severe patients at a cut-off value � 15.35 seconds (AUC: 0.90, 95% CI: 0.84–0.96). Moreover, alcohol drinkers were a 3.52 times more
likely chance of having severe disease than non-drinkers (95% CI: 1.41–8.81). A one-year
increment in age also increased the odds of disease severity by 6% (95% CI: 3–9%). An
increment of � 0.65 seconds from the baseline PT predicted poor prognosis (AUC: 0.93,
0.87–0.99) |
en_US |
dc.description.sponsorship |
uog |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
Prolonged baseline PT was observed in severe COVID-19 patients. Prolonged baseline PT was also predicted to worsen prognosis. An increase from the baseline PT was associated with worsen prognosis. Therefore, PT can be used as a risk stratification and prognostic marker in COVID-19 patients |
en_US |
dc.title |
Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients |
en_US |
dc.type |
Article |
en_US |